Proliferative retinopathy in a diabetic on interferon therapy: A diagnostic dilemma
Kerala Journal of Ophthalmology, 2016 Hepatitis C virus (HCV) is a blood-borne RNA virus that causes hepatitis C, chronic liver disease, and hepatocellular carcinoma. Patients with HCV infection are now treated with a combination of interferon alpha, which has antiviral and immunomodulatory ...
Prajina Rahul +4 more
doaj +1 more source
Interferon Alpha Association with Neuromyelitis Optica
Clinical and Developmental Immunology, 2013 Interferon-alpha (IFN-α) has immunoregulatory functions in autoimmune inflammatory diseases. The goal of this study was to determine occurrence and clinical consequences of IFN-α in neuromyelitis optica (NMO) patients.
Nasrin Asgari +5 more
doaj +1 more source
The sustained virologic response of nonresponder hepatitis C virus patients with retreatment
Indian Journal of Pathology and Microbiology, 2011 Background: Pegylated interferon and ribavirin combination therapy remain the first-line treatment for chronic hepatitis C virus (HCV) infection. In contrast to the large number of studies in treatment-naive patients, the effectiveness of retreatment in ...
Sila Cetin Akhan +2 more
doaj +1 more source
Use of Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma: A Retrospective Case Collection
Acta Dermato-Venereologica, 2023 Mycosis fungoides and Sézary syndrome are rare and largely incurable types of cutaneous T-cell lymphoma with limited therapeutic options. In 1984 Bunn et al.
Janika Gosmann +4 more
doaj +1 more source
Retinal Changes In Patients with Hepatitis C Virus under treatment with interferon and ribavirin. [PDF]
Egyptian Journal of Medical Research, 2020 Background: Chronic Hepatitis C is common problem worldwide treated by combination of interferon alpha and ribavirin. Retinopathy is one of the side effects of interferon therapy.
Mansour Hassan +3 more
doaj +1 more source
Acute Hepatitis Induced by Alpha-Interferon in a Patient with Chronic Hepatitis C
Canadian Journal of Gastroenterology, 2001 Hepatic adverse effects occur very rarely with alpha-interferon therapy. A case of acute hepatitis induced by alpha-interferon in a 33-year-old man with chronic hepatitis C is described.
Ivan Kraus, Dinko Vitezic
doaj +1 more source
THE IMMUNOCOMPETENT CELLS RECEPTORS RESEARCH UNDER EXPERIMENTAL INFLUENZA INFECTION IN VITRO
Инфекция и иммунитет, 2015 Introduction. It is known that interferon is a cytokine and is a substantial part of the immune system necessary for antigenic challenge immune response full expression. Also it is considered that every antigen is an interferon inducer.
A. N. Lisakov +6 more
doaj +1 more source
Тhe prophylactic efficacy of a recombinant interferon alfa-2b drug in children with bronchial asthma
Детские инфекции (Москва), 2019 A prospective cohort study was conducted to assess the effect of a recombinant interferon alpha-2b prophylactic course on cyto-immunological parameters of induced sputum in children with mild asthma, the main trigger of exacerbation of which was ...
Y. I. Zhakov +2 more
doaj +1 more source
New approaches and therapeutic modalities for the treatment of patients with chronic hepatitis C
Annals of Hepatology, 2005 A major challenge in the field of hepatology is the fight against hepatitis C that affects more than 150 million people world-wide. Despite the enormous improvement that has been achieved in the therapy of chronic hepatitis C over the last decade, there ...
Markus Cornberg, Michael P. Manns
doaj +1 more source
IFNα-mediated remodeling of endothelial cells in the bone marrow niche
Haematologica, 2017 In the bone marrow, endothelial cells are a major component of the hematopoietic stem cell vascular niche and are a first line of defense against inflammatory stress and infection.
Áine M. Prendergast +5 more
doaj +1 more source